Herpes, beyond skin manifestations, potentially impacts neurological and psychological health, with HHV-6 linked to mood ...

Growing research shows common herpes viruses may raise dementia risk, challenging previous skepticism and opening new paths ...

Assembly Biosciences is advancing its herpes drug to Phase II trials after it showed 94% antiviral efficacy in a Phase Ib ...

Assembly Biosciences ( NASDAQ: ASMB) reported promising results from an early stage study of its experimental candidate, ...

It’s estimated that, globally, around 67% of people under 50 have herpes simplex virus type 1 (HSV-1) infection, the main cause of oral herpes or cold sores, and around 13% have herpes simplex ...

The herpes simplex virus is very common and up to 80 percent of Swedish adults may be infected. The infection is lifelong, but the symptoms can come and go over different periods of life.

Mounting evidence suggests that herpes simplex virus 1 may be associated with an increased risk for Alzheimer’s disease and dementia, according to a systematic review of published studies ...

The link between herpes simplex and multiple sclerosis isn't fully understood by researchers, but there is an association between the two conditions.

The herpes virus is known for the painful, unsightly blisters it causes on the lips. However, herpes viruses can also induce encephalitis, especially in those with a weakened immune system. Prof.

GSK Plc has halted development of its herpes simplex virus vaccine, GSK3943104, after it failed to meet efficacy goals in clinical trials. Moderna and Pfizer's partner BioNTech are still ...

RP2 involves a weakened form of herpes simplex — the virus that causes cold sores — that has been modified to only infect tumors. Unlike other cancer drugs, it is injected directly into the tumor.